Cargando…
Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?
Congestion is the permanent mechanism driving disease progression in patients with acute heart failure (AHF) and also is an important treatment target. However, distinguishing between the two different phenotypes (intravascular congestion and tissue congestion) for personalized treatment remains cha...
Autores principales: | Feng, Rui, Zhang, Zhenlu, Fan, Qingkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644389/ https://www.ncbi.nlm.nih.gov/pubmed/38023127 http://dx.doi.org/10.3389/fonc.2023.1161723 |
Ejemplares similares
-
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure
por: Kumric, Marko, et al.
Publicado: (2021) -
Beyond malignancy: the role of carbohydrate antigen 125 in heart failure
por: Hung, Chung-Lieh, et al.
Publicado: (2013) -
Prognostic significance of carbohydrate antigen 125 in stage D heart failure
por: Zhang, Ji, et al.
Publicado: (2023) -
Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction
por: Falcão, F.J.A., et al.
Publicado: (2019) -
Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
por: Miñana, Gema, et al.
Publicado: (2022)